{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:03:39Z","timestamp":1789499019490,"version":"build-2803163510"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ningbo Public Welfare Science & Technology Major Projec","award":["2021S106"],"award-info":[{"award-number":["2021S106"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,26]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>This study aimed to elucidate the potential correlation between gut microbiota and intrahepatic cholangiocarcinoma (ICC) by investigating their causal relationship, while also exploring the possible role of immune cells as mediators in this association. We first identified gut microbiota based on phylum, class, order, family, and genus level information. Using summary-level data from a Genome-Wide Association Study (GWAS), we performed a 2-sample Mendelian randomization (MR) analysis of ICC and gut microbiota. Furthermore, we used 2-step MR to quantify the proportion of the effect of immune cell-mediated gut microbiota on ICC. MR analysis identified pyruvate fermentation to acetone (PFA) as predicting ICC risk reduction. There was no strong evidence that genetically predicted ICC had an effect on PFA risk. Furthermore, the proportion of genetically predicted PFA mediated by CD25hi CD45RA+ CD4 not Treg %T cell (CCCTT) was 3% (95% CI: 0.93\u20135.03%). In conclusion, our study established a causal relationship between PFA and ICC. We observed that a minor fraction of this effect was mediated by CCCTT, while the majority of the impact exerted by PFA on ICC remains elusive. However, further investigations are warranted to elucidate the mechanisms underlying the influence of gut microbiota on ICC development.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049498","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T18:01:15Z","timestamp":1782496875000},"page":"e49498","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Role of CD25hi CD45RA+ CD4 not Treg %T cell in mediating the effect of pyruvate fermentation to acetone on intrahepatic cholangiocarcinoma"],"prefix":"10.1097","volume":"105","author":[{"given":"Junyu","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5838-0542","authenticated-orcid":false,"given":"Hong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary and Pancreatic Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260915","first-page":"198","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians.","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"R2-20260915","doi-asserted-by":"crossref","first-page":"270","DOI":"10.21037\/hbsn.2018.03.16","article-title":"Cohort contributions to trends in the incidence and mortality of intrahepatic cholangiocarcinoma.","volume":"7","author":"Beal","year":"2018","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R3-20260915","doi-asserted-by":"crossref","first-page":"2156255","DOI":"10.1080\/19490976.2022.2156255","article-title":"Intratumor microbiome features reveal antitumor potentials of intrahepatic cholangiocarcinoma.","volume":"15","author":"Chai","year":"2023","journal-title":"Gut Microbes"},{"key":"R4-20260915","doi-asserted-by":"crossref","first-page":"e001383","DOI":"10.1136\/jitc-2020-001383","article-title":"Microbiome-derived metabolome as a potential predictor of response to cancer immunotherapy.","volume":"8","author":"Malczewski","year":"2020","journal-title":"J ImmunoTher Cancer"},{"key":"R5-20260915","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.7150\/ijbs.69331","article-title":"Gut microbiome in gastrointestinal cancer: a friend or foe?","volume":"18","author":"Liu","year":"2022","journal-title":"Int J Biol Sci"},{"key":"R6-20260915","doi-asserted-by":"crossref","first-page":"211","DOI":"10.21037\/hbsn.2019.10.11","article-title":"Clinical relevance of the relationship between changes in gut microbiota and bile acid metabolism in patients with intrahepatic cholangiocarcinoma.","volume":"9","author":"Herraez","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R7-20260915","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/cells12050793","article-title":"Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis.","volume":"12","author":"Wang","year":"2023","journal-title":"Cells"},{"key":"R8-20260915","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s41571-023-00770-1","article-title":"Cholangiocarcinoma \u2013 novel biological insights and therapeutic strategies.","volume":"20","author":"Ilyas","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"R9-20260915","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41588-021-00992-y","article-title":"Effect of host genetics on the gut microbiome in 7,738 participants of the Dutch Microbiome Project.","volume":"54","author":"Lopera-Maya","year":"2022","journal-title":"Nat Genet"},{"key":"R10-20260915","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","article-title":"Complex genetic signatures in immune cells underlie autoimmunity and inform therapy.","volume":"52","author":"Orr\u00f9","year":"2020","journal-title":"Nat Genet"},{"key":"R11-20260915","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1186\/s12888-023-05081-4","article-title":"Causal role of immune cells in schizophrenia: Mendelian randomization (MR) study.","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Psychiatry"},{"key":"R12-20260915","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/bioinformatics\/btz749","article-title":"Bayesian weighted Mendelian randomization for causal inference based on summary statistics.","volume":"36","author":"Zhao","year":"2020","journal-title":"Bioinformatics (Oxf)"},{"key":"R13-20260915","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome.","volume":"7","author":"Hemani","year":"2018","journal-title":"Elife"},{"key":"R14-20260915","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1093\/ije\/dyx102","article-title":"Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.","volume":"46","author":"Hartwig","year":"2017","journal-title":"Int J Epidemiol"},{"key":"R15-20260915","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R16-20260915","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1177\/0962280215597579","article-title":"A review of instrumental variable estimators for Mendelian randomization.","volume":"26","author":"Burgess","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"R17-20260915","first-page":"1961","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic.","volume":"45","author":"Bowden","year":"2016","journal-title":"Int J Epidemiol"},{"key":"R18-20260915","doi-asserted-by":"crossref","first-page":"808832","DOI":"10.3389\/fimmu.2022.808832","article-title":"No genetic causal association between periodontitis and arthritis: a bidirectional two-sample Mendelian randomization analysis.","volume":"13","author":"Yin","year":"2022","journal-title":"Front Immunol"},{"key":"R19-20260915","doi-asserted-by":"crossref","first-page":"e0247798","DOI":"10.1371\/journal.pone.0247798","article-title":"Characterization of biliary microbiota dysbiosis in extrahepatic cholangiocarcinoma.","volume":"16","author":"Saab","year":"2021","journal-title":"PLoS One"},{"key":"R20-20260915","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"R21-20260915","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"key":"R22-20260915","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/cells12030370","article-title":"Any role for microbiota in cholangiocarcinoma? A comprehensive review.","volume":"12","author":"Elvevi","year":"2023","journal-title":"Cells"},{"key":"R23-20260915","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1158\/2159-8290.CD-20-0304","article-title":"Gut microbiome directs hepatocytes to recruit MDSCs and promote cholangiocarcinoma.","volume":"11","author":"Zhang","year":"2021","journal-title":"Cancer Discov"},{"key":"R24-20260915","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3748\/wjg.v26.i21.2768","article-title":"Gut microbiome in primary sclerosing cholangitis: a review.","volume":"26","author":"Little","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R25-20260915","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD.","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"R26-20260915","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccell.2020.09.005","article-title":"A microbiota-derived metabolite augments cancer immunotherapy responses in mice.","volume":"38","author":"Allen-Vercoe","year":"2020","journal-title":"Cancer Cell"},{"key":"R27-20260915","doi-asserted-by":"crossref","first-page":"4178607","DOI":"10.1155\/2018\/4178607","article-title":"Gut microbial changes, interactions, and their implications on human lifecycle: an ageing perspective.","volume":"2018","author":"Vemuri","year":"2018","journal-title":"Biomed Res Int"},{"key":"R28-20260915","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cmet.2020.09.004","article-title":"The gut microbiota at the service of immunometabolism.","volume":"32","author":"Michaudel","year":"2020","journal-title":"Cell Metab"},{"key":"R29-20260915","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/nm.4106","article-title":"Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.","volume":"22","author":"Rothhammer","year":"2016","journal-title":"Nat Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049498","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:10:07Z","timestamp":1789495807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":29,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049498","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"2024-01-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}